PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IHE vs. FXAIX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between IHE and FXAIX is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.7

Performance

IHE vs. FXAIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares U.S. Pharmaceuticals ETF (IHE) and Fidelity 500 Index Fund (FXAIX). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-0.59%
9.99%
IHE
FXAIX

Key characteristics

Sharpe Ratio

IHE:

0.97

FXAIX:

2.17

Sortino Ratio

IHE:

1.43

FXAIX:

2.89

Omega Ratio

IHE:

1.17

FXAIX:

1.41

Calmar Ratio

IHE:

1.18

FXAIX:

3.21

Martin Ratio

IHE:

2.88

FXAIX:

14.15

Ulcer Index

IHE:

4.03%

FXAIX:

1.92%

Daily Std Dev

IHE:

12.03%

FXAIX:

12.50%

Max Drawdown

IHE:

-38.20%

FXAIX:

-33.79%

Current Drawdown

IHE:

-8.04%

FXAIX:

-2.20%

Returns By Period

In the year-to-date period, IHE achieves a 9.34% return, which is significantly lower than FXAIX's 26.49% return. Over the past 10 years, IHE has underperformed FXAIX with an annualized return of 4.27%, while FXAIX has yielded a comparatively higher 12.91% annualized return.


IHE

YTD

9.34%

1M

-2.52%

6M

-0.59%

1Y

10.82%

5Y*

6.00%

10Y*

4.27%

FXAIX

YTD

26.49%

1M

-0.16%

6M

9.99%

1Y

26.93%

5Y*

14.89%

10Y*

12.91%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


IHE vs. FXAIX - Expense Ratio Comparison

IHE has a 0.42% expense ratio, which is higher than FXAIX's 0.02% expense ratio.


IHE
iShares U.S. Pharmaceuticals ETF
Expense ratio chart for IHE: current value at 0.42% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.42%
Expense ratio chart for FXAIX: current value at 0.02% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.02%

Risk-Adjusted Performance

IHE vs. FXAIX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and Fidelity 500 Index Fund (FXAIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IHE, currently valued at 0.96, compared to the broader market0.002.004.000.972.17
The chart of Sortino ratio for IHE, currently valued at 1.43, compared to the broader market-2.000.002.004.006.008.0010.001.432.89
The chart of Omega ratio for IHE, currently valued at 1.17, compared to the broader market0.501.001.502.002.503.001.171.41
The chart of Calmar ratio for IHE, currently valued at 1.18, compared to the broader market0.005.0010.0015.001.183.21
The chart of Martin ratio for IHE, currently valued at 2.88, compared to the broader market0.0020.0040.0060.0080.00100.002.8814.15
IHE
FXAIX

The current IHE Sharpe Ratio is 0.97, which is lower than the FXAIX Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of IHE and FXAIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.50JulyAugustSeptemberOctoberNovemberDecember
0.97
2.17
IHE
FXAIX

Dividends

IHE vs. FXAIX - Dividend Comparison

IHE's dividend yield for the trailing twelve months is around 1.71%, more than FXAIX's 0.88% yield.


TTM20232022202120202019201820172016201520142013
IHE
iShares U.S. Pharmaceuticals ETF
1.71%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%1.20%1.06%
FXAIX
Fidelity 500 Index Fund
0.88%1.45%1.69%1.22%1.60%1.95%2.07%1.81%2.01%2.56%2.63%1.84%

Drawdowns

IHE vs. FXAIX - Drawdown Comparison

The maximum IHE drawdown since its inception was -38.20%, which is greater than FXAIX's maximum drawdown of -33.79%. Use the drawdown chart below to compare losses from any high point for IHE and FXAIX. For additional features, visit the drawdowns tool.


-10.00%-8.00%-6.00%-4.00%-2.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-8.04%
-2.20%
IHE
FXAIX

Volatility

IHE vs. FXAIX - Volatility Comparison

The current volatility for iShares U.S. Pharmaceuticals ETF (IHE) is 3.22%, while Fidelity 500 Index Fund (FXAIX) has a volatility of 3.74%. This indicates that IHE experiences smaller price fluctuations and is considered to be less risky than FXAIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JulyAugustSeptemberOctoberNovemberDecember
3.22%
3.74%
IHE
FXAIX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab